Your browser doesn't support javascript.
loading
Final analysis of the CLL2-GIVe trial: obinutuzumab, ibrutinib, and venetoclax for untreated CLL with del(17p)/TP53mut.
Huber, Henriette; Tausch, Eugen; Schneider, Christof; Edenhofer, Simone; von Tresckow, Julia; Robrecht, Sandra; Giza, Adam; Zhang, Can; Fürstenau, Moritz; Dreger, Peter; Ritgen, Matthias; Illmer, Thomas; Illert, Anna Lena; Dürig, Jan; Böttcher, Sebastian; Niemann, Carsten U; Kneba, Michael; Al-Sawaf, Othman; Kreuzer, Karl-Anton; Fink, Anna-Maria; Fischer, Kirsten; Döhner, Hartmut; Hallek, Michael; Eichhorst, Barbara; Stilgenbauer, Stephan.
Afiliação
  • Huber H; Sektion CLL, Klinik für Innere Medizin III, Universitätsklinikum Ulm, Ulm, Germany.
  • Tausch E; Medizinische Klinik III, Städtisches Klinikum Karlsruhe, Karlsruhe, Germany.
  • Schneider C; Sektion CLL, Klinik für Innere Medizin III, Universitätsklinikum Ulm, Ulm, Germany.
  • Edenhofer S; Sektion CLL, Klinik für Innere Medizin III, Universitätsklinikum Ulm, Ulm, Germany.
  • von Tresckow J; Sektion CLL, Klinik für Innere Medizin III, Universitätsklinikum Ulm, Ulm, Germany.
  • Robrecht S; Department I of Internal Medicine and Center of Integrated Oncology Aachen Cologne Bonn Duesseldorf, University Hospital of Cologne, Cologne, Germany.
  • Giza A; Clinic for Hematology and Stem Cell Transplantation, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
  • Zhang C; Department I of Internal Medicine and Center of Integrated Oncology Aachen Cologne Bonn Duesseldorf, University Hospital of Cologne, Cologne, Germany.
  • Fürstenau M; Department I of Internal Medicine and Center of Integrated Oncology Aachen Cologne Bonn Duesseldorf, University Hospital of Cologne, Cologne, Germany.
  • Dreger P; Department I of Internal Medicine and Center of Integrated Oncology Aachen Cologne Bonn Duesseldorf, University Hospital of Cologne, Cologne, Germany.
  • Ritgen M; Department I of Internal Medicine and Center of Integrated Oncology Aachen Cologne Bonn Duesseldorf, University Hospital of Cologne, Cologne, Germany.
  • Illmer T; Department Medicine V, University of Heidelberg, Heidelberg, Germany.
  • Illert AL; Klinik für Innere Medizin II, Universitätsklinikum Schleswig-Holstein, Kiel, Germany.
  • Dürig J; Group Practice for Hematology and Oncology, Dresden, Germany.
  • Böttcher S; Department of Medicine I, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Niemann CU; Deptartment of Internal Medicine, St. Josef Krankenhaus Werden, University Medicine Essen, Essen, Germany.
  • Kneba M; Medizinische Klinik III, Universitätsklinikum Rostock, Rostock, Germany.
  • Al-Sawaf O; Department of Clinical Medicine, Rigshospitalet, Copenhagen, Denmark.
  • Kreuzer KA; Klinik für Innere Medizin II, Universitätsklinikum Schleswig-Holstein, Kiel, Germany.
  • Fink AM; Department I of Internal Medicine and Center of Integrated Oncology Aachen Cologne Bonn Duesseldorf, University Hospital of Cologne, Cologne, Germany.
  • Fischer K; Department I of Internal Medicine and Center of Integrated Oncology Aachen Cologne Bonn Duesseldorf, University Hospital of Cologne, Cologne, Germany.
  • Döhner H; Department I of Internal Medicine and Center of Integrated Oncology Aachen Cologne Bonn Duesseldorf, University Hospital of Cologne, Cologne, Germany.
  • Hallek M; Department I of Internal Medicine and Center of Integrated Oncology Aachen Cologne Bonn Duesseldorf, University Hospital of Cologne, Cologne, Germany.
  • Eichhorst B; Sektion CLL, Klinik für Innere Medizin III, Universitätsklinikum Ulm, Ulm, Germany.
  • Stilgenbauer S; Department I of Internal Medicine and Center of Integrated Oncology Aachen Cologne Bonn Duesseldorf, University Hospital of Cologne, Cologne, Germany.
Blood ; 142(11): 961-972, 2023 09 14.
Article em En | MEDLINE | ID: mdl-37363867
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Blood Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Blood Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Alemanha